Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
mRNA-1273 Emergency use authorization Experimental Vaccine Jul/11/2022 28 1
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Mar/12/2022 17 1
Nitazoxanide Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/16/2021 7 1
Fluoxetine  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/15/2021 4 0
Bortezomib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021 3 0
Tilorone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 3 0
Cannabidiol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/14/2021 2 0
Aripiprazole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Thioridazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Trifluoperazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Excel (.xslx) CSV (.csv)